Paper read to the Ulster Medical Society, 12th March, 1970 . BY THE nature of our medical training on the subject of strokes we have come to regard them as pathological varieties, thrombotic, embolic or haemorrhagic, and, in facing their treatment, we probably have mental pictures of diseased blood vessels obstructed by clots, or emboli from a distant source of primary disease. Or we may carry with us a picture of an haemorrhage from the lenticulo-striate artery, examples of which are found in most student textbooks, rare as they are in clinical practice. We see a brain torn irremediably asunder by a dark red haemorrhage in the internal capsule. These pictures are rather daunting to the doctor concerned with treatment. He may have heard of some very dashing surgery to remove emboli and he may know of rare cases where removal of a cerebral haematoma temporarily improved a dismal situation. In the long term, anticoagulant therapy has its advocates for the prevention of further strokes; and there appears frequently in the literature an illustrious sea captain who was operated on for an incompletely obstructed carotid artery, after which he could write and talk properly which he could not do before operation. After we have finished with surgical possibilities we turn to the fruitful field of rehabilitation. But the immediate prospect for the patient who becomes suddenly hemiplegic this day is not encouraging.
It is not right that this should be so, because, in the last 10 years, the medical profession has realized that cardiac infarction is a treatable disorder. The coronary sufferer has an area of ischaemic muscle which cannot survive very long without glucose and oxygen, the stroke sufferer has an area of ischaemic brain which cannot survive long without glucose and oxygen. They both have the same pathological lesion -obstruction of an arterial branch, large or small, and it is an identical local manifestation of a general disorder which everyone above the age of 16 has more or less -the scourge of twentieth-century man -arteriosclerosis.
Why then do we rush to the coronary sufferer's aid on the street or in his home and wring our hands over the stroke sufferer? The reason is that their biochemical and physiological problem is not the same, although their arterial lesions are. Ischaemic cardiac muscle under conditions of anaerobic glycolysis loses intracellular potassium and becomes irritable and subject to arrhythmias. Severe untreated arrhythmia -ventricular fibrillation -is fatal and is the almost invariable cause of death in the first few hours. lschaemic brain also becomes acidotic and, to a lesser extent, irritable; but electrical instability in the brain may have no clinical manifestations or, at the worst, may be expressed as an epileptic seizure which is a non-fatal condition. The tendency of the stroke patient is towards improvement, not sudden death, as the normal circulation of the surrounding brain comes to the aid of the oxygen-deprived infarct. For this reason medical science has not found it necessary to stir its ingenuity to help limit cerebral infarction as it has to limit cardiac infarction, and the attitude of mind which says "You can do nothing about a stroke" has persisted to the present time.
There is, however, no reason why it should be allowed to persist any longer and it is the purpose of this paper to set forth the measures which can reasonably be taken to reduce immediate damage to the brain of the stroke patient. I should make it clear that, from this point on, I am talking about vascular occlusions and making the assumption that all the necessary measures have been taken to exclude the presence of haemorrhage -subarachnoid or intra cerebral. The extent of the brain damage caused by vascular occlusion will be partly determined by the condition of the cerebral arterial tree at the time of ictus. A young man spontaneously thrombosing his internal carotid artery may experience a very brief hemiplegia or none at all. The surrounding arteries are probably healthy and resilient and can quickly dilate to bring oxygen and glucose to where they are required. The aged arteriosclerotic patient is less likely to be able to compensate for a major artery occlusion as his available reserves for dilatation are less. About this situation so far the eager therapist can do nothing, but he can act to use the available vessels to their maximum. To see why he can act we must go back a few years to one of the most important observations in the history of cerebral physiology made -as such observations often are -casually, and without full realization at the time of their significance. Feindel & Perot (1965) observed, at operations in the Montreal Neurological Institute, red veins emerging from an area of old infarction and scarring. These veins were carrying blood highly saturated with oxygen. The following year physiologists from Copenhagen (Lassen, 1966) described hyperaemia surrounding areas of acute infarction and this was confirmed by their radiologists who could show areas of increased perfusion on angiograms. This phenomenon was given the title of "luxury perfusion" or "intracerebral steal". These are bad terms because they have no scientific meaning and smack of the occult. It could be more properly called 'para-ischaemic hyperaemia' which is accurately descriptive. It occurs because of the metabolic change in anoxic brain resulting in the accumulation of CO2 and lactates and a fall in tissue pH. This is of such a degree that the small vessels in the vicinity all dilate maximally. At the same time the collateral vessels are also dilating in response to a fall in intravascular pressure setting up a high to low pressure gradient. Well oxidized arterial blood is now reaching fully dilated arterioles and capillaries and makes its way to the veins still oxygen-saturated and under a higher than normal pressure. It is difficult to believe that nature should behave in this wasteful way in a cerebral emergency, but it has been shown that this hyperaemia happens predictably under controlled experimental conditions. The important factor emerging from these observations is that, as a result of the paradoxical behaviour of blood vessels, CO2 normally increasing blood flow in the brain by acting as a dilator of cerebral vessels, now decreases blood flow by dilating the collateral vessels and allowing blood to bleed out of the infarcted area. Fortunately the converse is also true. The behaviour of normal and ischaemic brain in response to inhaled CO2 can be well shown in an experiment described*. A cat's left middle *This was illustrated by the author. Unfortunately the figure was lost at a late period by the block makers and, with the author's temporary absence abroad, we have been compelled to go to press without the line block. Editor. cerebral artery had been occluded at operation one week before. When inhalation of C02 began blood flow increased on both the normal right and ischaemic left side. After a few seconds blood flow fell steadily on the left side while it continued to rise on the right until the C02 was shut off, when blood flow returned to normal over an equal number of seconds, rising on the ischaemic and falling on the normal side. The blood flow reacts to C02 in a manner directly opposite to the normal physiological response. For the converse reasons, reduction of circulating 0.02 mediates a reduction of blood flow in the normal brain and an increased blood flow in an ischaemic area distal to an arterial obstruction.
That therapeutic use could be made of this paradox was first shown by Soloway (1968) . In a series of cats with ligated middle cerebral arteries, he showed that the area of infarcted brain was much larger in untreated dogs than in those treated by prolonged hyperventilation, reducing the arterial PCO2 to around 20 mg. The stage would now appear to be set for the introduction of controlled hyperventilation in the treatment of cerebral vascular obstruction. Clinicians have, so far, been doubtful about the risks involved because, in the absence of regional monitoring apparatus, it is difficult to record directly the effect that hypocapnia is having on the infarcted area at the time of hyperventilation. However, Rossanda and Gordon (1969) have recorded a fall in mortality of 15 per cent in the treatment of coma of all types since the introduction of prolonged hyperventilation into their resuscitation regime. It is a droll contradiction that one of the first treatments of stroke ever proposed, rebreathing from a paper bag to raise arterial p002, may now be shown to produce the exact opposite of the desired therapeutic result.
As oxygen lack is the big cause of cerebral tissue death, it would seem probable that the administration of oxygen under pressure would support the cellular activity required to ensure survival until the circulatory reserves could come to the rescue. A rising p02, however, causes cerebral vasoconstriction and it has been found experimentally that the resulting fall in cerebral blood flow more than counters the effectiveness of a rising intravascular oxygen content. Hyperbaric oxygen has so far proved disappointing in practice in the treatment of strokes.
The inability of oxygen by itself to preserve cell life and activity underlines the fact that the cell's metabolic needs are multiple. In over-simplified terms, the minimum cell requirements in the partial absence of oxidative glycolysis would appear to be another energy source, either anaerobic glycolysis or the intracellular breakdown of lipoprotein or amino-acids. The hypoxic brains of diffusely arteriosclerotic elderly patients showing symptoms of early or advanced dementia, are benefitted metabolically and clinically by the infusion of glucose and insulin. Metabolically it is found that cerebral glucose utilization increases, and clinically the patients' performance in memory, orientation and attention tests improves. It should be noted that glucose infusion alone does not cause this improvement, nor does insulin alone, which first causes hypoglycaemia and actually reduces glucose oxidation. As oxygen alone is also unsuccessful in stroke therapy, it may be that we also have to give some enzyme or some high energy phosphate compound with it before it assists oxidative glycolysis, apparently the most essential activity to maintain life in nervous tissue.
Having mentioned the possibility that phospholipids might help the project of keeping a cerebral infarct as small as possible, mention can finally be made of some work done in Chicago and contributed to by a distinguished alumnus of this School, Dr. Sean Mullan. Working in a team headed by Dr. Ishii (Ishii, 1966) he showed that cat brain made anoxic by extradural compression could be assisted electrically and functionally by the infusion of cytidine diphosphate choline (CDP). When the animal had reached the stage of drowsiness and stupor and when the EEG. record had become slow and irregular, intravenous infusion restored restless and eventually purposeful activity, and returned the EEG. to a normal rhythm. These effects lasted for 40-50 minutes, after which the animal's conscious level relapsed.
This discourse is becoming more speculative, but it retains its clear objectiveto utilize the biochemical knowledge we possess to keep as many cerebral cells as possible working and therefore living until the collateral circulation comes to the aid of brain temporarily struggling with hypoxia. In this we have the same aim as the cardiologists, to reduce the infarct to the smallest possible volume. To the cardiac patient the prize is life, to the brain-damaged patient the prize is a much more active and higher quality survival. A stroke should not be thought of as a harbinger of death, or even doom. Two of the last three American presidents had ischaemic coronary or cerebral attacks before they began four years of what must have been one of the most demanding and stressful jobs in the world, and they both survived the completion of their tasks to enjoy further years of useful, active life. We should now accept the challenge offered to medicine by the stroke as we have answered the challenge of coronary thrombosis.
